Clinical Trial Update: G-CSF in Decompensated Cirrhosis: an Open Label Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on G-CSF for decompensated liver cirrhosis across Phase 2 and Phase 3 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis Liver

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Cirrhosis, Liver | Phase 2, Phase 3 | Status: UNKNOWN